Exercise for Patients With HIV Infections
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00910936 |
Recruitment Status
: Unknown
Verified December 2009 by Charite University, Berlin, Germany.
Recruitment status was: Recruiting
First Posted
: June 1, 2009
Last Update Posted
: December 21, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections Lipodystrophy Inflammation | Behavioral: Exercise | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Supportive Care |
Official Title: | Effects of an Exercise Program on Metabolic Parameters of Patients With a HIV Infection. |
Study Start Date : | May 2009 |
Estimated Primary Completion Date : | January 2010 |
Estimated Study Completion Date : | February 2010 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention |
Behavioral: Exercise
12 weeks endurance training, 3 times weekly for 35 minutes
|
No Intervention: Control |
- Maximal oxygen uptake (VO2max) [ Time Frame: At recruitment and after 12 weeks ]
- Quality of life [ Time Frame: At recruitment and after 12 weeks ]
- Indicators of fat metabolism [ Time Frame: At recruitment and after 12 weeks ]
- Markers of inflammation [ Time Frame: At recruitment and after 12 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18 to 65
- HIV infection
- Antiviral therapy
- Understanding of written German
Exclusion Criteria:
- Diabetes mellitus
- All conditions which can be aggravated by exercise

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00910936
Contact: Fernando Dimeo, MD | +493084452098 | fernando.dimeo@charite.de |
Germany | |
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30 | Recruiting |
Berlin, Germany, 12200 | |
Contact: Fernando Dimeo, MD +493084452098 fernando.dimeo@charite.de |
Principal Investigator: | Fernando Dimeo, MD | Charite University, Berlin, Germany |
Responsible Party: | Dr. Fernando Dimeo, Dept. of Sports Medicine, Charité Universitätsmedizin Berlin |
ClinicalTrials.gov Identifier: | NCT00910936 History of Changes |
Other Study ID Numbers: |
EA04/050/07 |
First Posted: | June 1, 2009 Key Record Dates |
Last Update Posted: | December 21, 2009 |
Last Verified: | December 2009 |
Keywords provided by Charite University, Berlin, Germany:
HIV Exercise Inflammation Quality of life Lipodystrophia |
Additional relevant MeSH terms:
Infection Communicable Diseases Inflammation HIV Infections Acquired Immunodeficiency Syndrome Lipodystrophy Pathologic Processes Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases Skin Diseases, Metabolic Skin Diseases Lipid Metabolism Disorders Metabolic Diseases |